blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2461811

EP2461811 - MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.02.2017
Database last updated on 16.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Idenix Pharmaceuticals LLC
320 Bent Street, Floor 4
Cambridge, MA 02141 / US
[2016/16]
Former [2016/02]For all designated states
Idenix Pharmaceuticals LLC.
320 Bent Street, Floor 4
Cambridge, MA 02141 / US
Former [2013/21]For all designated states
IDENIX Pharmaceuticals, Inc.
320 Bent Street, Floor 4
Cambridge, MA 02141 / US
Former [2012/24]For all designated states
IDENIX Pharmaceuticals, Inc.
60 Hampshire Street
Cambridge, MA 02139 / US
Inventor(s)01 / PARSY, Christophe Claude
6 Rue des Cedres
F-34830 Jacou / FR
02 / ALEXANDRE, Francois-Rene
Residence Occitanie
200 Avenue du Major Flandre
F-34090 Montpellier / FR
03 / LEROY, Frederic
5 Rue de la Clairette
F-34570 Montarnaud / FR
04 / CONVARD, Thierry
7 Avenue de Bel Air
F-69580 Sathonay-camp / FR
05 / SURLERAUX, Dominique
Rue de la Scaillee 13
B-1440 Wauthier-Braine / BE
 [2012/24]
Representative(s)Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[2016/16]
Former [2013/52]Savic, Bojan, et al
Jones Day
Rechtsanwälte Attorneys-at-Law Patentanwälte
Prinzregentenstraße 11
80538 München / DE
Former [2012/24]Ritter, Thomas Kurt
Jones Day
Prinzregentenstraße 11
80538 München / DE
Application number, filing date10745691.504.08.2010
[2016/16]
WO2010US44334
Priority number, dateUS20090231636P05.08.2009         Original published format: US 231636 P
[2012/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011017389
Date:10.02.2011
Language:EN
[2011/06]
Type: A1 Application with search report 
No.:EP2461811
Date:13.06.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2011 takes the place of the publication of the European patent application.
[2012/24]
Type: B1 Patent specification 
No.:EP2461811
Date:20.04.2016
Language:EN
[2016/16]
Search report(s)International search report - published on:EP10.02.2011
ClassificationIPC:A61K31/4709, C07D417/04, A61P31/14
[2012/24]
CPC:
C07D417/14 (EP,US); A61K31/403 (EP,US); A61K31/4709 (EP,US);
A61P1/16 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/24]
Extension statesBANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:MAKROCYCLISCHE SERINPROTEASEHEMMER GEGEN VIRALE INFEKTIONEN, IM BESONDEREN HVC[2012/24]
English:MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV[2012/24]
French:INHIBITEURS MACROCYCLIQUES DE LA SÉRINE PROTÉASE MACROCYCLIQUE UTILES CONTRE LES INFECTIONS VIRALES, EN PARTICULIER LE VIRUS DE L'HÉPATITE C[2015/50]
Former [2012/24]INHIBITEURS MACROCYCLIQUES DE LA SÉRINE PROTÉASE MACROCYCLIQUE UTILES CONTRE LES INFECTIONS VIRALES, EN PARTICULIER LE VIRUS DE L HÉPATITE C
Entry into regional phase20.02.2012National basic fee paid 
20.02.2012Designation fee(s) paid 
20.02.2012Examination fee paid 
Examination procedure20.02.2012Examination requested  [2012/24]
13.09.2012Amendment by applicant (claims and/or description)
09.04.2013Despatch of a communication from the examining division (Time limit: M06)
16.10.2013Reply to a communication from the examining division
01.04.2014Despatch of a communication from the examining division (Time limit: M06)
08.10.2014Reply to a communication from the examining division
12.03.2015Despatch of a communication from the examining division (Time limit: M06)
17.09.2015Reply to a communication from the examining division
09.11.2015Communication of intention to grant the patent
01.03.2016Fee for grant paid
01.03.2016Fee for publishing/printing paid
01.03.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.04.2013
Opposition(s)23.01.2017No opposition filed within time limit [2017/13]
Fees paidRenewal fee
10.08.2012Renewal fee patent year 03
19.08.2013Renewal fee patent year 04
13.08.2014Renewal fee patent year 05
07.08.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.08.2010
AL20.04.2016
AT20.04.2016
BE20.04.2016
BG20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IS20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
MK20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
TR20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
MT31.08.2016
[2018/46]
Former [2018/38]HU04.08.2010
AT20.04.2016
BE20.04.2016
BG20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IS20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
MK20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
TR20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
MT31.08.2016
Former [2018/33]HU04.08.2010
AT20.04.2016
BE20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IS20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
MK20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
TR20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
MT31.08.2016
Former [2018/30]HU04.08.2010
AT20.04.2016
BE20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IS20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
MK20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
TR20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
Former [2018/29]HU04.08.2010
AT20.04.2016
BE20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
MK20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
TR20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
Former [2018/28]HU04.08.2010
AT20.04.2016
BE20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
MK20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
Former [2017/37]AT20.04.2016
BE20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
NO20.07.2016
GR21.07.2016
IE04.08.2016
LU04.08.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
Former [2017/23]AT20.04.2016
BE20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
MC20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SI20.04.2016
SK20.04.2016
SM20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
CH31.08.2016
LI31.08.2016
Former [2017/11]AT20.04.2016
BE20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SK20.04.2016
SM20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2017/10]AT20.04.2016
BE20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
SK20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2017/09]AT20.04.2016
BE20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
RO20.04.2016
SE20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2017/07]AT20.04.2016
BE20.04.2016
DK20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
SE20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2017/03]AT20.04.2016
BE20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
IT20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
SE20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2016/52]AT20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
SE20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2016/51]AT20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
NO20.07.2016
GR21.07.2016
PT22.08.2016
Former [2016/50]AT20.04.2016
ES20.04.2016
FI20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
NL20.04.2016
PL20.04.2016
NO20.07.2016
Former [2016/49]FI20.04.2016
LT20.04.2016
NL20.04.2016
PL20.04.2016
NO20.07.2016
Former [2016/46]LT20.04.2016
NO20.07.2016
Cited inInternational search[Y]WO2007014926  (TIBOTEC PHARM LTD [IE], et al) [Y] 1-89 * page 134; claims 1-20; compound 48 *;
 [Y]WO2009085978  (ENANTA PHARCEUTICALS INC [US], et al) [Y] 1-89 * claims 1, 5-15 *;
 [A]US2008286233  (SUN YING [US], et al) [A] 1-89 * the whole document *;
 [AP]WO2009099596  (IDENIX PHARAMACEUTICALS INC [US], et al) [AP] 1-89 * the whole document *
by applicantUS5538865
 US5990276
 US6143715
 US6265380
 US6323180
 US6329379
 US6410531
 US6420380
 US6534523
 US6608027
 US6642204
 US6653295
 US6727366
 US6838475
 US6846802
 US6867185
 US6869964
 US6872805
 US6878722
 US6908901
 US6911428
 US6995174
 US7012066
 US7041698
 US7091184
 US7169760
 US7176208
 US7208600
 US7491794
 US2002016294
 US2002016442
 US2002032175
 US2002037998
 US2004229777
 US2005090450
 US2005153877
 US2005176648
 US2006046956
 US2007021330
 US2007021351
 US2007049536
 US2007054842
 US2007060510
 US2007060565
 US2007072809
 US2007078081
 US2007078122
 US2007093414
 US2007093430
 US2007099825
 US2007099929
 US2007105781
 US2008152622
 US2009035271
 US2009035272
 US2009111969
 US2009111982
 US2009123425
 US2009130059
 US2009148407
 US2009156800
 US2009169510
 US2009175822
 US2009180981
 WO9817679
 WO9822496
 WO9907734
 WO0009543
 WO0059929
 WO0208187
 WO0208251
 WO0208256
 WO0208198
 WO0248116
 WO0248157
 WO0248172
 WO02060926
 WO03053349
 WO03064416
 WO03064455
 WO03064456
 WO03066103
 WO03099274
 WO03099316
 WO2004032827
 WO2004043339
 WO2005037214
 WO2005037860
 WO2006000085
 WO2006119061
 WO2006122188
 WO2007001406
 WO2007014925
 WO2007014926
 WO2007015824
 WO2007056120
 WO2008019289
 WO2008021960
 WO2008022006
 WO2008086161
 WO2009053828
 WO2009058856
 WO2009073713
 WO2009073780
 WO2009080542
 WO2009082701
 WO2009082697
 WO2009085978
 US2009152622
 WO2009014730
 US4328245
 US4409239
 US4410545
 US6350458
 US3845770
 US3916899
 US3536809
 US3598123
 US4008719
 US5674533
 US5059595
 US5591767
 US5120548
 US5073543
 US5639476
 US5354556
 US5639480
 US5733566
 US5739108
 US5891474
 US5922356
 US5958458
 US5972891
 US5980945
 US5993855
 US6045830
 US6087324
 US6113943
 US6197350
 US6248363
 US6264970
 US6267981
 US6270798
 US6375987
 US6376461
 US6419961
 US6589548
 US6613358
 US6623756
 US6699500
 US6793936
 US6827947
 US6902742
 US6958161
 US7255876
 US7416738
 US7427414
 US7485322
 US5798119
 US5612059
 US5698220
 WO0217918
 US5709874
 US5759542
 US5840674
 US5900252
 US5972366
 US5985307
 US6004534
 US6039975
 US6048736
 US6060082
 US6071495
 US6120751
 US6131570
 US6139865
 US6253872
 US6271359
 US6274552
 US6316652
 US7169410
 DE19914474
 US6004933
 US5633358
 WO9736554
 WO03070750
 WO2005012525
 US2004209831
 JPH08268890
 JPH10101591
 US6043077
 US5869253
 US5610054
 US6660721
 US6777395
 US6784166
 US6846810
 US6927291
 US7094770
 US7105499
 US7125855
 US7202224
 US2004121980
 US2005009737
 US2005038240
 US2006040890
 WO9943691
 WO0132153
 WO0160315
 WO0179246
 WO0190121
 WO0192282
 WO0218404
 WO0232920
 WO0248165
 WO02057425
 WO02057287
 WO2004002422
 WO2004002999
 WO2004003000
 US6034134
 US5922757
 US5846964
 US5830905
 US5633388
 US5496546
 US5026687
 US5891874
 US5725859
 US5837257
 US6056961
 US5323907
 US5052558
 US5033252
 WO2007014919
    - KUO ET AL., SCIENCE, (1989), vol. 244, pages 362 - 364
    - THOMAS, CURR. TOP. MICROBIOL. IMMUNOL., (2000), pages 25 - 41
    - DI BESCEGLIE ET AL., SCIENTIFIC AMERICAN, (199910), pages 80 - 85
    - BOYER ET AL., J HEPATOL., (2000), vol. 32, pages 98 - 112
    - KATO ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 9524 - 9528
    - KATO, ACTA MEDICA OKAYAMA, (2001), vol. 55, pages 133 - 159
    - POYNARD ET AL., LANCET, (1998), vol. 352, pages 1426 - 1432
    - MANNS ET AL., LANCET, (2001), vol. 358, pages 958 - 965
    - FRIED ET AL., N. ENGL. J. MED., (2002), vol. 347, pages 975 - 982
    - HADZIYANNIS ET AL., ANN. INTERN. MED., (2004), vol. 140, pages 346 - 355
    - LLINAS-BRUNET ET AL., BIOORG. MED. CHEM. LETT., (1998), vol. 8, pages 1713 - 1718
    - STEINKUHLER ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 8899 - 8905
    - BERGE ET AL., J PHARM. SCI., (1977), vol. 66, pages 1 - 19
    - HARPER, PROGRESS IN DRUG RESEARCH, (1962), vol. 4, pages 221 - 294
    - GANGWAR ET AL., DES. BIOPHARM. PROP. PRODRUGS ANALOGS, (1977), pages 409 - 421
    - BUNDGAARD, ARCH. PHARM. CHEM., (1979), vol. 86, pages 1 - 39
    - FARQUHAR ET AL., J. PHARM. SCI., (1983), vol. 72, pages 324 - 325
    - WERNUTH ET AL., Drug Design: Fact or Fantasy, ACADEMIC PRCSS, (1984), pages 47 - 72
    - FLEISHER ET AL., METHODS ENZYMOL., (1985), vol. 112, pages 360 - 381
    - STELLA ET AL., DRUGS, (1985), vol. 29, pages 455 - 473
    - BUNDGAARD, CONTROLLED DRUG DELIVERY, (1987), vol. 17, pages 179 - 96
    - WALLER ET AL., BR. J. CLIN. PHARMAC., (1989), vol. 28, pages 497 - 507
    - BALANT ET AL., EUR. J. DRUG METAB. PHARMACOKINET., (1990), vol. 15, pages 143 - 53
    - FREEMAN ET AL., J. CHEM. SOC., CHEM. COMMUN., (1991), pages 875 - 877
    - BUNDGAARD, ADV. DRUG DELIVERY REV., (1992), vol. 8, pages 1 - 38
    - NATHWANI; WOOD, DRUGS, (1993), vol. 45, pages 866 - 94
    - FRIIS; BUNDGAARD, EUR. J. PHARM. SCI., (1996), vol. 4, pages 49 - 59
    - FLEISHER ET AL., ADV. DRUG DELIVERY REV., (1996), vol. 19, pages 115 - 130
    - SINHABABU; THAKKER, ADV. DRUG DELIVERY REV., (1996), vol. 19, pages 241 - 273
    - TAYLOR, ADV. DRUG DELIVERY REV., (1996), vol. 19, pages 131 - 148
    - GAIGNAULT ET AL., PRACT. MED. CHEM., (1996), pages 671 - 696
    - BROWNE, CLIN. NEUROPHARMACOL., (1997), vol. 20, pages 1 - 12
    - VALENTINO; BORCHARDT, DRUG DISCOVERY TODAY, (1997), vol. 2, pages 148 - 155
    - PAULETTI ET AL., ADV. DRUG. DELIVERY REV., (1997), vol. 27, pages 235 - 256
    - MIZEN ET AL., PHARM. BIOTECH., (1998), vol. 11, pages 345 - 365
    - WIEBE; KNAUS, ADV. DRUG DELIVERY REV., (1999), vol. 39, pages 63 - 80
    - TAN ET AL., ADV. DRUG DELIVERY REV., (1999), vol. 39, pages 117 - 151
    - BALIMANE; SINKO, ADV. DRUG DELIVERY REV., (1999), vol. 39, pages 183 - 209
    - WANG ET AL., CURR. PHARM. DESIGN, (1999), vol. 5, pages 265 - 287
    - HAN ET AL., AAPS PHARMSCI., (2000), vol. 2, pages 1 - 11
    - ASGHAMEJAD ET AL., Transport Processes in Pharmaceutical Systems, MARCCLL DCKKCR, (2000), pages 185 - 218
    - SINHA ET AL., PHARM. RES., (2001), vol. 18, pages 557 - 564
    - ANAND ET AL., EXPERT OPIN. BIOL. THER., (2002), vol. 2, pages 607 - 620
    - RAO, RESONACE, (2003), pages 19 - 27
    - SLOAN ET AL., MED. RES. REV., (2003), vol. 23, pages 763 - 793
    - PATTERSON ET AL., CURR. PHARM. DES., (2003), vol. 9, pages 2131 - 2154
    - HU, IDRUGS, (2004), vol. 7, pages 736 - 742
    - ROBINSON ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2004), vol. 101, pages 14527 - 14532
    - ERION ET AL., J. PHARMACOL. EXP. THER., (2005), vol. 312, pages 554 - 560
    - FANG ET AL., CURR. DRUG DISCOV. TECHNOL., (2006), vol. 3, pages 211 - 224
    - STANCZAK ET AL., PHARMACOL. REP., (2006), vol. 58, pages 599 - 613
    - SLOAN ET AL., PHARM. RES., (2006), vol. 23, pages 2729 - 2747
    - STELLA ET AL., ADV. DRUG DELIV. REV., (2007), vol. 59, pages 677 - 694
    - GOMES ET AL., MOLECULES, (2007), vol. 12, pages 2484 - 2506
    - KRAFZ ET AL., CHEMMEDCHEM, (2008), vol. 3, pages 20 - 53
    - RAUTIO ET AL., AAPS J., (2008), vol. 10, pages 92 - 102
    - RAUTIO ET AL., NAT. REV. DRUG. DISCOV., (2008), vol. 7, pages 255 - 270
    - PAVAN ET AL., MOLECULES, (2008), vol. 13, pages 1035 - 1065
    - SANDROS ET AL., MOLECULES, (2008), vol. 13, pages 1156 - 1178
    - SINGH ET AL., CURR. MED. CHEM., (2008), vol. 15, pages 1802 - 1826
    - ONISHI ET AL., MOLECULES, (2008), vol. 13, pages 2136 - 2155
    - HUTTUNEN ET AL., CURR. MED. CHEM., (2008), vol. 15, pages 2346 - 2365
    - SERAFIN ET AL., MINI REV. MED. CHEM., (2009), vol. 9, pages 481 - 497
    - BUSSEMER ET AL., CRIT. REV. THER. DRUG CARRIER SYST., (2001), vol. 18, pages 433 - 458
    - MARONI ET AL., EXPERT. OPIN. DRUG DELIV., (2005), vol. 2, pages 855 - 871
    - SHI ET AL., EXPERT OPIN. DRUG DELIV., (2005), vol. 2, pages 1039 - 1058
    - BADAWY ET AL., J PHARM. SCI., (2007), vol. 9, pages 948 - 959
    - CONWAY, RECENT PAT. DRUG DELIV. FORMUL., (2008), vol. 2, pages 1 - 8
    - GAZZANIGA ET AL., EUR. J. PHARM. BIOPHARRN., (2008), vol. 68, pages 11 - 18
    - NAGARWAL ET AL., CURR. DRUG DELIV., (2008), vol. 5, pages 282 - 289
    - GALLARDO ET AL., PHARM. DEV. TECHNOL., (2008), vol. 13, pages 413 - 423
    - CHRZANOWSKI, AAPS PHARMSCITECH., (2008), vol. 9, pages 635 - 638
    - CHRZANOWSKI, AAPS PHARNISCITECH., (2008), vol. 9, pages 639 - 645
    - KALANTZI, RECENT PAT. DRUG DELIV. FORMUL., (2009), vol. 3, pages 49 - 63
    - SAIGAL ET AL., RECENT PAT. DRUG DELIV. FORMUL., (2009), vol. 3, pages 64 - 70
    - ROY ET AL., J. CONTROL RELEASE, (2009), vol. 134, pages 74 - 80
    - TAKADA ET AL., Encyclopedia of Controlled Drug Delivery, WILEY, (1999), vol. 2
    - SANTUS; BAKER, J. CONTROLLED RELEASE, (1995), vol. 35, pages 1 - 21
    - VERMA, DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, (2000), vol. 26, pages 695 - 708
    - VERMA ET AL., J. CONTROLLED RELEASE, (2002), vol. 79, pages 7 - 27
    - ATTWOOD ET AL., ANTIVIRAL CHEMISTRY AND CHEMOTHERAPY, (1999), vol. 10, pages 259 - 273
    - SUDO ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1997), vol. 238, pages 643 - 647
    - CHU ET AL., TETRAHEDRON LETTERS, (1996), vol. 37, pages 7229 - 7232
    - CHU ET AL., BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (1999), vol. 9, pages 1949 - 1952
    - QASIM ET AL., BIOCHEMISTRY, (1997), vol. 36, pages 1598 - 1607
    - STEINKIIHLER ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 8899 - 8905
    - SUDO ET AL., ANTIVIRAL RESEARCH, (1996), vol. 32, pages 9 - 18
    - KAKIUCHI ET AL., FEBS LETT., (1998), vol. 421, pages 217 - 220
    - TAKESHITA ET AL., ANALYTICAL BIOCHEMISTRY, (1997), vol. 247, pages 242 - 246
    - FERRARI ET AL., JOURNAL OF VIROLOGY, (1999), vol. 73, pages 1649 - 1654
    - LOHMANN ET AL., VIROLOGY, (1998), vol. 249, pages 108 - 118
    - ALT ET AL., HEPATOLOGY, (1995), vol. 22, pages 707 - 717
    - ALT ET AL., ARCHIVES OF VIROLOGY, (1997), vol. 142, pages 589 - 599
    - GALDERISI ET AL., JOURNAL OF CELLULAR PHYSIOLOGY, (1999), vol. 181, pages 251 - 257
    - TAREMI ET AL., PROTEIN SCIENCE, (1998), vol. 7, pages 2143 - 2149
    - WAKITA ET AL., NAT. MED., (2005), vol. 11, pages 791 - 796
    - ZHONG ET AL., PROC. NAT. ACAD. SCI. USA., (2005), vol. 102, pages 9294 - 9299
    - J. ORG. CHEM., (2006), vol. 71, pages 8864 - 8875
 US20090149662
 US20090231408
 US20090365127
 US20090167847
 US20090231600
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.